Related Experiment Video
Updated: Oct 1, 2025
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases
Shenrui Guo1, Hui Wang1, Yafu Yin1
1Department of Nuclear Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Microglia-mediated neuroinflammation is a common feature of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). Microglia can be categorized into two opposite types: classical (M1) or alternative (M2), though there's a continuum of different intermediate phenotypes between M1 and M2, and microglia can transit from one phenotype to another. M1 microglia release inflammatory mediators and induce inflammation and neurotoxicity, while M2 microglia release anti-inflammatory mediators and induce anti-inflammatory and neuroprotectivity. Microglia-mediated neuroinflammation is considered as a double-edged sword, performing both harmful and helpful effects in neurodegenerative diseases. Previous studies showed that balancing microglia M1/M2 polarization had a promising therapeutic prospect in neurodegenerative diseases. We suggest that shifting microglia from M1 to M2 may be significant and we focus on the modulation of microglia polarization from M1 to M2, especially by important signal pathways, in neurodegenerative diseases.
Insights
Neuroinflammation involves microglia, immune cells in the brain. Shifting microglia from M1 (harmful) to M2 (helpful) states shows therapeutic potential for neurodegenerative diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Immunology
Background:
- Microglia-mediated neuroinflammation is central to neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and MS.
- Microglia exist on a spectrum from M1 (pro-inflammatory, neurotoxic) to M2 (anti-inflammatory, neuroprotective) phenotypes.
Purpose of the Study:
- To explore the therapeutic potential of modulating microglia polarization in neurodegenerative diseases.
- To focus on shifting microglia from the M1 to the M2 phenotype.
Main Methods:
- Review of existing literature on microglia polarization in neurodegenerative conditions.
- Analysis of signaling pathways involved in M1/M2 microglia transition.
Main Results:
- Microglia polarization is a double-edged sword, with both detrimental and beneficial roles.
- Balancing M1/M2 polarization presents a promising therapeutic strategy.
Conclusions:
- Modulating microglia polarization, specifically promoting the M2 phenotype, is a significant therapeutic avenue.
- Targeting key signaling pathways offers a route to achieve beneficial microglia shifts in neurodegenerative diseases.
